These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23608470)

  • 1. Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles.
    Jain D; Athawale R; Bajaj A; Shrikhande S; Goel PN; Gude RP
    Colloids Surf B Biointerfaces; 2013 Sep; 109():59-67. PubMed ID: 23608470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.
    Santander-Ortega MJ; Jódar-Reyes AB; Csaba N; Bastos-González D; Ortega-Vinuesa JL
    J Colloid Interface Sci; 2006 Oct; 302(2):522-9. PubMed ID: 16887138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles.
    d'Angelo I; Parajó Y; Horváth A; Kéri G; La Rotonda MI; Alonso MJ
    J Microencapsul; 2010; 27(1):57-66. PubMed ID: 19545221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
    Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosylated polymeric nanoparticles: a sweetened approach against blood compatibility paradox.
    Thasneem YM; Sajeesh S; Sharma CP
    Colloids Surf B Biointerfaces; 2013 Aug; 108():337-44. PubMed ID: 23563302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.
    Mayol L; Serri C; Menale C; Crispi S; Piccolo MT; Mita L; Giarra S; Forte M; Saija A; Biondi M; Mita DG
    Eur J Pharm Biopharm; 2015 Jun; 93():37-45. PubMed ID: 25794477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
    Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.
    Guo C; Gemeinhart RA
    Eur J Pharm Biopharm; 2008 Oct; 70(2):597-604. PubMed ID: 18602994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(D,L-lactide-co-glycolide) dispersions containing pluronics: from particle preparation to temperature-triggered aggregation.
    Fraylich M; Wang W; Shakesheff K; Alexander C; Saunders B
    Langmuir; 2008 Aug; 24(15):7761-8. PubMed ID: 18570443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration.
    Semete B; Booysen L; Kalombo L; Ramalapa B; Hayeshi R; Swai HS
    Int J Pharm; 2012 Mar; 424(1-2):115-20. PubMed ID: 22227605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel.
    Bansal A; Wu X; Olson V; D'Souza MJ
    Int J Pharm; 2018 Jul; 545(1-2):318-328. PubMed ID: 29746999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery.
    Csaba N; Caamaño P; Sánchez A; Domínguez F; Alonso MJ
    Biomacromolecules; 2005; 6(1):271-8. PubMed ID: 15638530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface modification of HSA containing magnetic PLGA nanoparticles by poloxamer to decrease plasma protein adsorption.
    Shubhra QTH; Tóth J; Gyenis J; Feczkó T
    Colloids Surf B Biointerfaces; 2014 Oct; 122():529-536. PubMed ID: 25092588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
    Choi SW; Kim JH
    J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
    Zhang WL; Liu JP; Liu XX; Chen ZQ
    Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved delivery of the natural anticancer drug tetrandrine.
    Shi C; Ahmad Khan S; Wang K; Schneider M
    Int J Pharm; 2015 Feb; 479(1):41-51. PubMed ID: 25510598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.